I'm going to answer the question in English. I can answer it in French as well.
Patients, we hope, will continue to have that relationship with their physicians. We're concerned that this relationship will break down if they're having to pay additional taxes, and if there's no difference between what they're paying to get it from a pharmacy or from a licensed producer than getting it from a corner store. I think they really benefit from that engagement with their physician.
At Tilray, we have 150 pediatric patients. A lot of these patients suffer from seizure disorder, in some cases with over 100 seizures a day. I would never want to tell one of those families to go down to the corner store or to the LCBO equivalent to pick up their medicine. It's just not going to be the same experience as going through their physician to be able to get medical cannabis.
At the same time, what we're about to do is charge that same family the same price, the same taxation rate, for their medical cannabis to stop seizure disorder as we're going to charge a 25-year-old going into the store to pick up a few grams for the weekend, and that's the problem. We're not recognizing this medical need. We're not recognizing the financial challenges that come when they're accessing a medicine that isn't covered by our provincial registries right now, and ultimately that means we're going to have worse public health and personal health outcomes.
That is really my main concern.